Teva (TEVA) stock Forecast for 2022 – 2026
Last update: 05-20-2022, 8:32Sector: Healthcare
The share price of Teva Pharmaceutical Industries Lim. (TEVA) (TEVA) now
What analysts predict:: $10.81
52-week high/low: $11.55 / $7.23
50/200 Day Moving Average: $8.69 / $8.9
This figure corresponds to the average price over the previous 50/200 days. For Teva stocks, the 50-day moving average is the resistance level today.
For Teva stocks, the 200-day moving average is the resistance level today.
Are you interested in Teva Pharmaceutical Industries Lim. (TEVA) stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Teva stock price in 2022, 2023, 2024, 2025, 2026. How much will one Teva share be worth in 2022 - 2026?
When should I take profit in Teva stock? When should I record a loss on Teva stock? What are analysts' forecasts for Teva stock? What is the future of Teva stock?
We forecast Teva stock performance using neural networks based on historical data on Teva stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Teva stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Teva shares. This happens once a day.
Historical and forecast chart of Teva stock
The chart below shows the historical price of Teva stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Teva stock price can be found in the table below.
Long-term forecasts by years.
Teva daily forecast for a month
Teva Daily Price Targets
Teva Stock Forecast 05-22-2022.
Pessimistic target level: 7.95
Optimistic target level: 8.59
Teva Stock Forecast 05-23-2022.
Pessimistic target level: 8.05
Optimistic target level: 8.38
Teva Stock Forecast 05-24-2022.
Pessimistic target level: 8.27
Optimistic target level: 8.69
Teva Stock Forecast 05-25-2022.
Pessimistic target level: 8.13
Optimistic target level: 8.71
Teva Stock Forecast 05-26-2022.
Pessimistic target level: 8.15
Optimistic target level: 8.69
Teva Stock Forecast 05-27-2022.
Pessimistic target level: 8.19
Optimistic target level: 8.84
TEVA (TEVA) Monthly Stock Prediction for 2022
Teva forecast for this year
Teva Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $8.59795. Pessimistic: $7.62. Optimistic: $9.55
Teva Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $7.99266. Pessimistic: $7.31. Optimistic: $8.50
Teva Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $7.77526. Pessimistic: $7.09. Optimistic: $8.76
Teva Stock Prediction for Sep 2022
An uptrend is forecast for this month with an optimal target price of $8.01162. Pessimistic: $7.43. Optimistic: $8.65
Teva Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $7.24251. Pessimistic: $6.94. Optimistic: $7.64
Teva Stock Prediction for Nov 2022
An downtrend is forecast for this month with an optimal target price of $7.18457. Pessimistic: $6.52. Optimistic: $7.53
Teva Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $8.16167. Pessimistic: $7.44. Optimistic: $8.54
Teva (TEVA) Monthly Stock Prediction for 2023
Teva (TEVA) Monthly Stock Prediction for 2024
Teva (TEVA) Monthly Stock Prediction for 2025
Teva (TEVA) Monthly Stock Prediction for 2026
Teva information and performance
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets and distributes generics, specialty drugs and biopharmaceutical products in North America, Europe and internationally. The company offers sterile products, hormones, high potency drugs and cytotoxic agents in a variety of dosage forms, including tablets, capsules, injections, inhalers, liquids, ointments and creams. It also develops, manufactures and markets active pharmaceutical ingredients. In addition, the company provides specialized medicines for use in the central nervous system and respiratory indications. In addition, its products in the central nervous system and pain areas include Copaxone for the treatment of relapsing forms of MS; ADZHOVIY for the prophylactic treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington’s disease. In addition, the company’s products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair / Cinqaero and AirDuo RespiClick / ArmonAir RespiClick / AirDuo Digihaler for asthma and chronic obstructive pulmonary disease, as well as Bendeka products , Trisenox, Lonquex and Tevagrastim / Ratiograstim in the cancer market. She has cooperation agreements with Otsuka Pharmaceutical Co. LTD. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petah Tikva, Israel.
5 BAZEL ST, P O B 3190, PETACH TIKVA, IL
Market Capitalization: 9 326 939 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 4 409 000 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 22.22
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 0.197
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0.469
Quarterly Revenue Growth YOY: -0.079
Trailing PE: 22.22
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 3.19
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 1.911
Enterprise Value (EV) /Revenue
EV To EBITDA: 17.71
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 1110350000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Teva (TEVA) stock dividend
Teva last paid dividends on 11/27/2017. The next scheduled payment will be on 12/12/2017. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.